ThermoGenesis Sees Explosive Growth Opportunities in Stem Cells

Mel Engle, CEO of ThermoGenesis [NASDAQ: KOOL] recently discussed with OneMedRadio, the company’s stem cell products and FDA approval that may have groundbreaking implications for the stem cell market.

Read more »